Pharmaceutical

Innate Pharma plans IND of ADC candidate after positive preclinical data

Innate Pharma plans to advance IPH45 towards clinical trials, with an investigational new drug (IND) application planned in 2024.

Apr 11, 2024 - 00:00
Innate Pharma plans IND of ADC candidate after positive preclinical data
Innate Pharma plans to advance IPH45 towards clinical trials, with an investigational new drug (IND) application planned in 2024.
Read the original article

Tags:

Previous Article

Pharmaceutical cleanrooms and cleanroom flooring suppliers

Next Article

Novartis plans to axe 680 employees

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Pharmaceutical Technology Excellence Awards 2024: PCI Pharma Services 

Pharmaceutical Technology Excellence Awards 2024: PCI P...

Nov 27, 2024

Evotec shuts down gene therapy business in light of Q1 2024 loss 

Evotec shuts down gene therapy business in light of Q1 ...

May 23, 2024

STAT+: Pharmalittle: Pfizer halts development of twice-daily obesity pill; Supreme Court to review Purdue bankruptcy deal

STAT+: Pharmalittle: Pfizer halts development of twice-...

Dec 1, 2023